{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":null,"value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"cg-2","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"S","per_page":12,"people":[{"id":426410,"version":1,"owner_type":"Person","owner_id":3373,"payload":{"bio":"\u003cp\u003eDan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.\u0026nbsp; Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.\u0026nbsp; Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations;\u0026nbsp;the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);\u0026nbsp; antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.\u0026nbsp; Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.\u0026nbsp; In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\u003c/p\u003e\n\u003cp\u003eThe Special Matters \u0026amp; Government Investigations group has been twice recognized by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e\u0026nbsp;as the \u0026ldquo;White-Collar Group of the Year\u0026rdquo; and described as \u0026ldquo;the premier firm in this practice area\u0026rdquo; by the\u0026nbsp;\u003cem\u003eU.S. News \u0026amp; World Report/Best Lawyers\u0026rsquo;\u003c/em\u003e\u0026nbsp;\u0026ldquo;Best Law Firms\u0026rdquo; survey.\u003c/p\u003e\n\u003cp\u003eDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland. \u0026nbsp;He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDan holds Top Secret/SCI security clearances until their expiration.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement\u003c/em\u003e, Washington Legal Foundation Legal Backgrounder (2016)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eRecent Trends in Health Care Enforcement and Compliance\u003c/em\u003e, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe Future of Off-Label Promotion Enforcement in the Wake of Caronia \u0026mdash; Toward a First Amendment Safe Harbor\u003c/em\u003e, The Sedona Conference Journal, Volume 14 (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eOff-Label Promotion: The Criminalization of Scientific Exchange\u003c/em\u003e, Pharma Magazine (UK) (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement\u003c/em\u003e, ABA White Collar Crime (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States\u003c/em\u003e, The Tax Lawyer, Volume 63 (2010)\u003c/li\u003e\n\u003c/ul\u003e","slug":"daniel-sale","email":"dsale@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in connection with the Special Counsel investigation conducted by Robert Mueller.\u003c/p\u003e","\u003cp\u003eRepresenting a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.\u003c/p\u003e","\u003cp\u003eSecured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues\u003c/p\u003e","\u003cp\u003eRepresented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.\u003c/p\u003e","\u003cp\u003eRepresenting several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.\u003c/p\u003e","\u003cp\u003eRepresented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys\u0026rsquo; Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;litigation.\u003c/p\u003e","\u003cp\u003eRepresented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":1,"source":"smartTags"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":20,"guid":"20.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"},{"id":5,"guid":"5.capabilities","index":11,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":12,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":13,"source":"capabilities"},{"id":7,"guid":"7.capabilities","index":14,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Sale","nick_name":"Daniel","clerkships":[{"name":"Law Clerk, Richard D. Bennett, U.S. District Court for the District of Maryland","years_held":"2010-2012"}],"first_name":"Daniel","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2010-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/daniel-sale-27063baa/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.\u0026nbsp; Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.\u0026nbsp; Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations;\u0026nbsp;the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);\u0026nbsp; antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.\u0026nbsp; Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.\u0026nbsp; In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\u003c/p\u003e\n\u003cp\u003eThe Special Matters \u0026amp; Government Investigations group has been twice recognized by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e\u0026nbsp;as the \u0026ldquo;White-Collar Group of the Year\u0026rdquo; and described as \u0026ldquo;the premier firm in this practice area\u0026rdquo; by the\u0026nbsp;\u003cem\u003eU.S. News \u0026amp; World Report/Best Lawyers\u0026rsquo;\u003c/em\u003e\u0026nbsp;\u0026ldquo;Best Law Firms\u0026rdquo; survey.\u003c/p\u003e\n\u003cp\u003eDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland. \u0026nbsp;He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDan holds Top Secret/SCI security clearances until their expiration.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement\u003c/em\u003e, Washington Legal Foundation Legal Backgrounder (2016)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eRecent Trends in Health Care Enforcement and Compliance\u003c/em\u003e, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe Future of Off-Label Promotion Enforcement in the Wake of Caronia \u0026mdash; Toward a First Amendment Safe Harbor\u003c/em\u003e, The Sedona Conference Journal, Volume 14 (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eOff-Label Promotion: The Criminalization of Scientific Exchange\u003c/em\u003e, Pharma Magazine (UK) (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement\u003c/em\u003e, ABA White Collar Crime (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States\u003c/em\u003e, The Tax Lawyer, Volume 63 (2010)\u003c/li\u003e\n\u003c/ul\u003e","matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in connection with the Special Counsel investigation conducted by Robert Mueller.\u003c/p\u003e","\u003cp\u003eRepresenting a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.\u003c/p\u003e","\u003cp\u003eSecured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues\u003c/p\u003e","\u003cp\u003eRepresented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.\u003c/p\u003e","\u003cp\u003eRepresenting several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.\u003c/p\u003e","\u003cp\u003eRepresented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys\u0026rsquo; Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;litigation.\u003c/p\u003e","\u003cp\u003eRepresented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12360}]},"capability_group_id":2},"created_at":"2025-05-26T04:52:35.000Z","updated_at":"2025-05-26T04:52:35.000Z","searchable_text":"Sale{{ FIELD }}Representing pro bono a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.{{ FIELD }}Representing an individual in connection with the Special Counsel investigation conducted by Robert Mueller.{{ FIELD }}Representing a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.{{ FIELD }}Secured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues{{ FIELD }}Represented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.{{ FIELD }}Representing several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.{{ FIELD }}Represented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys’ Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act qui tam litigation.{{ FIELD }}Represented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.{{ FIELD }}Dan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.  Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.  Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations; the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);  antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations. \nDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.  Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.  In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\nThe Special Matters \u0026amp; Government Investigations group has been twice recognized by Law 360 as the “White-Collar Group of the Year” and described as “the premier firm in this practice area” by the U.S. News \u0026amp; World Report/Best Lawyers’ “Best Law Firms” survey.\nDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland.  He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player. \nDan holds Top Secret/SCI security clearances until their expiration.\nPublications\n\nDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\nThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement, Washington Legal Foundation Legal Backgrounder (2016)\nRecent Trends in Health Care Enforcement and Compliance, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\nThe Future of Off-Label Promotion Enforcement in the Wake of Caronia — Toward a First Amendment Safe Harbor, The Sedona Conference Journal, Volume 14 (2013)\nOff-Label Promotion: The Criminalization of Scientific Exchange, Pharma Magazine (UK) (2013)\nFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement, ABA White Collar Crime (2013)\nTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States, The Tax Lawyer, Volume 63 (2010)\n Partner Yale University Yale Law School Georgetown University Georgetown University Law Center U.S. Court of Appeals for the Fourth Circuit U.S. District Court for the District of Maryland District of Columbia Maryland Law Clerk, Richard D. Bennett, U.S. District Court for the District of Maryland Representing pro bono a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon. Representing an individual in connection with the Special Counsel investigation conducted by Robert Mueller. Representing a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations. Secured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues Represented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016. Representing several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges. Represented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys’ Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act qui tam litigation. Represented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.","searchable_name":"Daniel C. Sale","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426475,"version":1,"owner_type":"Person","owner_id":3801,"payload":{"bio":"\u003cp\u003eIlana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\u003c/p\u003e\n\u003cp\u003eBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA\u0026rsquo;s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\u003c/p\u003e\n\u003cp\u003eIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA\u0026rsquo;s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana\u0026rsquo;s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\u003c/p\u003e\n\u003cp\u003eAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\u003c/p\u003e\n\u003cp\u003eIn 2015 and 2016, Ilana received recognition for environmental law in the \u003cem data-redactor-tag=\"em\"\u003eLegal 500 U.S.\u003c/em\u003e guide.\u003c/p\u003e","slug":"ilana-saltzbart","email":"isaltzbart@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":16,"guid":"16.capabilities","index":0,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":5,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":6,"source":"capabilities"},{"id":1015,"guid":"1015.smart_tags","index":7,"source":"smartTags"},{"id":984,"guid":"984.smart_tags","index":8,"source":"smartTags"},{"id":1143,"guid":"1143.smart_tags","index":9,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":10,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":11,"source":"smartTags"},{"id":125,"guid":"125.capabilities","index":12,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":13,"source":"smartTags"},{"id":1269,"guid":"1269.smart_tags","index":14,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Saltzbart","nick_name":"Ilana","clerkships":[],"first_name":"Ilana","title_rank":9999,"updated_by":176,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"Top Ranked Lawyer\", Environment ","detail":"Chambers USA, District of Columbia (2021-2022)"},{"title":"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights ","detail":"Chambers USA (2022)"},{"title":"Environmental Law ","detail":"Legal 500 U.S., 2015 and 2016"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eIlana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\u003c/p\u003e\n\u003cp\u003eBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA\u0026rsquo;s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\u003c/p\u003e\n\u003cp\u003eIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA\u0026rsquo;s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana\u0026rsquo;s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\u003c/p\u003e\n\u003cp\u003eAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\u003c/p\u003e\n\u003cp\u003eIn 2015 and 2016, Ilana received recognition for environmental law in the \u003cem data-redactor-tag=\"em\"\u003eLegal 500 U.S.\u003c/em\u003e guide.\u003c/p\u003e","recognitions":[{"title":"\"Top Ranked Lawyer\", Environment ","detail":"Chambers USA, District of Columbia (2021-2022)"},{"title":"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights ","detail":"Chambers USA (2022)"},{"title":"Environmental Law ","detail":"Legal 500 U.S., 2015 and 2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1162}]},"capability_group_id":2},"created_at":"2025-05-26T04:53:37.000Z","updated_at":"2025-05-26T04:53:37.000Z","searchable_text":"Saltzbart{{ FIELD }}{:title=\u0026gt;\"\\\"Top Ranked Lawyer\\\", Environment \", :detail=\u0026gt;\"Chambers USA, District of Columbia (2021-2022)\"}{{ FIELD }}{:title=\u0026gt;\"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights \", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Environmental Law \", :detail=\u0026gt;\"Legal 500 U.S., 2015 and 2016\"}{{ FIELD }}Ilana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.\nIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\nBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA’s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\nIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA’s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana’s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\nAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\nIn 2015 and 2016, Ilana received recognition for environmental law in the Legal 500 U.S. guide. Partner \"Top Ranked Lawyer\", Environment  Chambers USA, District of Columbia (2021-2022) Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights  Chambers USA (2022) Environmental Law  Legal 500 U.S., 2015 and 2016 District of Columbia Maryland","searchable_name":"Ilana Saltzbart","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":176,"capability_group_featured":null,"home_page_featured":null},{"id":426539,"version":1,"owner_type":"Person","owner_id":4092,"payload":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"kyle-sampson","email":"ksampson@kslaw.com","phone":"+1 202 340 8202","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":6,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Sampson","nick_name":"D.","clerkships":[{"name":"Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit","years_held":"1996-1997"}],"first_name":"D.","title_rank":9999,"updated_by":202,"law_schools":[{"id":2174,"meta":{"degree":"J.D.","honors":"with honors","is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Kyle","name_suffix":"","recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}],"linked_in_url":"https://www.linkedin.com/in/kyle-sampson-4302348/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12357}]},"capability_group_id":2},"created_at":"2025-05-26T04:54:31.000Z","updated_at":"2025-05-26T04:54:31.000Z","searchable_text":"Sampson{{ FIELD }}{:title=\u0026gt;\"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America \", :detail=\u0026gt;\"U.S. Department of Justice, 2005\"}{{ FIELD }}Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.{{ FIELD }}Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization.{{ FIELD }}Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.{{ FIELD }}Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.{{ FIELD }}Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice.{{ FIELD }}With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.{{ FIELD }}Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients.{{ FIELD }}Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.{{ FIELD }}Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.{{ FIELD }}Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE).{{ FIELD }}Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.{{ FIELD }}\nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n{{ FIELD }}As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.{{ FIELD }}Kyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\n\nKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\nKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\n \n  Partner Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America  U.S. Department of Justice, 2005 Brigham Young University J. Reuben Clark Law School University of Chicago University of Chicago Law School U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Utah District of Columbia Utah Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions. Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization. Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters. Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions. Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice. With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program. Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients. Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations. Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy. Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE). Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act. \nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.","searchable_name":"D. Kyle Sampson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426468,"version":1,"owner_type":"Person","owner_id":3787,"payload":{"bio":"\u003cp\u003eWilliam (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.\u0026nbsp; As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.\u0026nbsp; He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHis recent environmental matters include representation of several\u0026nbsp;auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\u003c/p\u003e\n\u003cp\u003eIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets.\u003c/p\u003e","slug":"william-sauers","email":"wsauers@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":252}]},"expertise":[{"id":106,"guid":"106.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":3,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":4,"source":"smartTags"},{"id":16,"guid":"16.capabilities","index":5,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":6,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":7,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":8,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Sauers","nick_name":"Bill","clerkships":[],"first_name":"William","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWilliam (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.\u0026nbsp; As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.\u0026nbsp; He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHis recent environmental matters include representation of several\u0026nbsp;auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\u003c/p\u003e\n\u003cp\u003eIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6104}]},"capability_group_id":2},"created_at":"2025-05-26T04:53:31.000Z","updated_at":"2025-05-26T04:53:31.000Z","searchable_text":"Sauers{{ FIELD }}William (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.  As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.  He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.\nHis recent environmental matters include representation of several auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\nIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets. William J. Sauers Partner Supreme Court of the United States District of Columbia Pennsylvania","searchable_name":"William J. Sauers (Bill)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":436424,"version":1,"owner_type":"Person","owner_id":3557,"payload":{"bio":"\u003cp\u003eHeather Saul is a partner\u0026nbsp;in King \u0026amp; Spalding\u0026rsquo;s Special Matters practice in the firm's Atlanta office. Her practice focuses on government investigations and enforcement actions, as well as crisis management for clients across industries. She also defends executives and companies in white-collar criminal defense matters, including qui tam litigation and other litigation under a variety of statutes. Heather\u0026nbsp;also conducts corporate compliance reviews and provides ongoing compliance advice.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHeather previously served as a law clerk to the Honorable Eleanor L. Ross of the United States\u0026nbsp;District Court for the Northern District of Georgia.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHeather received her Juris Doctor,\u0026nbsp;\u003cem\u003ecum laude\u003c/em\u003e, from New York University School of Law, where she served as a Staff Editor of the \u003cem\u003eNew York University Annual Survey of American Law\u003c/em\u003e. During law school, Heather interned with the U.S. Attorney's Offices for the\u0026nbsp;Eastern and Southern Districts of New York, in the criminal and civil divisions, respectively. Heather earned her undergraduate degrees in Biological Science and Spanish, \u003cem\u003emagna cum laud\u003c/em\u003e\u003cem\u003ee,\u0026nbsp;with high honors\u003c/em\u003e,\u0026nbsp;from The University of Georgia,\u0026nbsp;where she was inducted into the national honor society of Sigma Delta Pi.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"heather-saul","email":"hsaul@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":2,"source":"smartTags"},{"id":973,"guid":"973.smart_tags","index":3,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":4,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":5,"source":"smartTags"},{"id":113,"guid":"113.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Saul","nick_name":"Heather","clerkships":[{"name":"Law Clerk, The Honorable Eleanor L. Ross, U.S. District Court for the Northern District of Georgia","years_held":"2017 - 2018"}],"first_name":"Heather","title_rank":9999,"updated_by":202,"law_schools":[{"id":1406,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":1,"graduation_date":"2015-01-01 00:00:00 UTC"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eHeather Saul is a partner\u0026nbsp;in King \u0026amp; Spalding\u0026rsquo;s Special Matters practice in the firm's Atlanta office. Her practice focuses on government investigations and enforcement actions, as well as crisis management for clients across industries. She also defends executives and companies in white-collar criminal defense matters, including qui tam litigation and other litigation under a variety of statutes. Heather\u0026nbsp;also conducts corporate compliance reviews and provides ongoing compliance advice.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHeather previously served as a law clerk to the Honorable Eleanor L. Ross of the United States\u0026nbsp;District Court for the Northern District of Georgia.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHeather received her Juris Doctor,\u0026nbsp;\u003cem\u003ecum laude\u003c/em\u003e, from New York University School of Law, where she served as a Staff Editor of the \u003cem\u003eNew York University Annual Survey of American Law\u003c/em\u003e. During law school, Heather interned with the U.S. Attorney's Offices for the\u0026nbsp;Eastern and Southern Districts of New York, in the criminal and civil divisions, respectively. Heather earned her undergraduate degrees in Biological Science and Spanish, \u003cem\u003emagna cum laud\u003c/em\u003e\u003cem\u003ee,\u0026nbsp;with high honors\u003c/em\u003e,\u0026nbsp;from The University of Georgia,\u0026nbsp;where she was inducted into the national honor society of Sigma Delta Pi.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11828}]},"capability_group_id":2},"created_at":"2025-09-02T04:52:58.000Z","updated_at":"2025-09-02T04:52:58.000Z","searchable_text":"Saul{{ FIELD }}Heather Saul is a partner in King \u0026amp; Spalding’s Special Matters practice in the firm's Atlanta office. Her practice focuses on government investigations and enforcement actions, as well as crisis management for clients across industries. She also defends executives and companies in white-collar criminal defense matters, including qui tam litigation and other litigation under a variety of statutes. Heather also conducts corporate compliance reviews and provides ongoing compliance advice. \nHeather previously served as a law clerk to the Honorable Eleanor L. Ross of the United States District Court for the Northern District of Georgia.  \nHeather received her Juris Doctor, cum laude, from New York University School of Law, where she served as a Staff Editor of the New York University Annual Survey of American Law. During law school, Heather interned with the U.S. Attorney's Offices for the Eastern and Southern Districts of New York, in the criminal and civil divisions, respectively. Heather earned her undergraduate degrees in Biological Science and Spanish, magna cum laude, with high honors, from The University of Georgia, where she was inducted into the national honor society of Sigma Delta Pi.\n  Partner University of Georgia University of Georgia School of Law University of Georgia University of Georgia School of Law New York University New York University School of Law Georgia American Bar Association Atlanta Bar Association Georgia State Bar Law Clerk, The Honorable Eleanor L. Ross, U.S. District Court for the Northern District of Georgia","searchable_name":"Heather Saul","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442389,"version":1,"owner_type":"Person","owner_id":1036,"payload":{"bio":"\u003cp\u003eChristine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChristine has over 25\u0026nbsp;years of experience helping clients handle their\u0026nbsp;international trade regulatory, compliance, and investigation needs.\u0026nbsp; She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.\u0026nbsp; She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings\u0026nbsp; and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.\u0026nbsp; She also represents\u0026nbsp;clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for\u0026nbsp;legislative and regulatory solutions to help advance their trade and investment goals.\u003c/p\u003e\n\u003cp\u003ePreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.\u0026nbsp; In that\u0026nbsp;role, she acted as counsel to the government in\u0026nbsp;trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\u003c/p\u003e\n\u003cp\u003eChristine was recommended by \u003cem\u003eLegal 500 U.S.\u003c/em\u003e in the International Trade category. She is recognized by \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers U.S.A.\u003c/em\u003e in the International Trade: Export Controls \u0026amp; Economic Sanctions category.\u003c/p\u003e","slug":"christine-savage","email":"csavage@kslaw.com","phone":null,"matters":["\u003cp\u003eAssisted\u0026nbsp;\u003cstrong\u003eenergy, infrastructure, defense, and biotechnology companies\u003c/strong\u003e\u0026nbsp;in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eseveral U.S. and non-U.S. aerospace and defense companies\u003c/strong\u003e\u0026nbsp;in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ecompanies in the FinTech industry\u003c/strong\u003e\u0026nbsp;with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.\u003c/p\u003e","\u003cp\u003eAssisted in obtaining clearance by CFIUS for\u0026nbsp;\u003cstrong\u003ecompanies in sensitive sectors, including defense, critical technology, and critical infrastructure industries\u0026nbsp;\u003c/strong\u003eof foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003enumerous clients in the pharmaceutical, medical device and agricultural industries\u003c/strong\u003e\u0026nbsp;in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":25,"guid":"25.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":1327,"guid":"1327.smart_tags","index":2,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":3,"source":"capabilities"},{"id":1330,"guid":"1330.smart_tags","index":4,"source":"smartTags"},{"id":23,"guid":"23.capabilities","index":5,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":6,"source":"smartTags"},{"id":1142,"guid":"1142.smart_tags","index":7,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":8,"source":"capabilities"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":10,"source":"smartTags"},{"id":579,"guid":"579.smart_tags","index":11,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":12,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":13,"source":"capabilities"},{"id":1233,"guid":"1233.smart_tags","index":14,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":15,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":16,"source":"capabilities"}],"is_active":true,"last_name":"Savage","nick_name":"Christine","clerkships":[],"first_name":"Christine","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"E.","name_suffix":"","recognitions":[{"title":"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions","detail":"Legal 500 USA (2025)"},{"title":"\"Christine has a deep understanding of this area of law and gets all aspects.\"","detail":"Chambers USA, Nationwide (2025)"},{"title":"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”","detail":"Chambers USA (2023)"},{"title":"“Christine explores legal options with clients to meet business needs and legal obligations.”","detail":"Chambers USA (2023)"},{"title":"“She is able to give practical advice which is solution-orientated.”","detail":"Chambers USA (2023)"},{"title":"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”","detail":" Chambers USA (2022)"},{"title":"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”","detail":"Chambers Global (2022)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions ","detail":"Chambers Global, USA (2012, 2018-2025)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions","detail":"Chambers USA, Nationwide (2010-2011, 2017-2025)"},{"title":"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”","detail":"Chambers USA (2018)"},{"title":"Top Rated International Lawyer","detail":"Super Lawyers, Washington, D.C."},{"title":"Recognized Practitioner","detail":"Legal 500 US"}],"linked_in_url":"https://www.linkedin.com/in/christinesavage/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChristine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChristine has over 25\u0026nbsp;years of experience helping clients handle their\u0026nbsp;international trade regulatory, compliance, and investigation needs.\u0026nbsp; She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.\u0026nbsp; She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings\u0026nbsp; and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.\u0026nbsp; She also represents\u0026nbsp;clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for\u0026nbsp;legislative and regulatory solutions to help advance their trade and investment goals.\u003c/p\u003e\n\u003cp\u003ePreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.\u0026nbsp; In that\u0026nbsp;role, she acted as counsel to the government in\u0026nbsp;trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\u003c/p\u003e\n\u003cp\u003eChristine was recommended by \u003cem\u003eLegal 500 U.S.\u003c/em\u003e in the International Trade category. She is recognized by \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers U.S.A.\u003c/em\u003e in the International Trade: Export Controls \u0026amp; Economic Sanctions category.\u003c/p\u003e","matters":["\u003cp\u003eAssisted\u0026nbsp;\u003cstrong\u003eenergy, infrastructure, defense, and biotechnology companies\u003c/strong\u003e\u0026nbsp;in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eseveral U.S. and non-U.S. aerospace and defense companies\u003c/strong\u003e\u0026nbsp;in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ecompanies in the FinTech industry\u003c/strong\u003e\u0026nbsp;with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.\u003c/p\u003e","\u003cp\u003eAssisted in obtaining clearance by CFIUS for\u0026nbsp;\u003cstrong\u003ecompanies in sensitive sectors, including defense, critical technology, and critical infrastructure industries\u0026nbsp;\u003c/strong\u003eof foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003enumerous clients in the pharmaceutical, medical device and agricultural industries\u003c/strong\u003e\u0026nbsp;in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.\u003c/p\u003e"],"recognitions":[{"title":"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions","detail":"Legal 500 USA (2025)"},{"title":"\"Christine has a deep understanding of this area of law and gets all aspects.\"","detail":"Chambers USA, Nationwide (2025)"},{"title":"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”","detail":"Chambers USA (2023)"},{"title":"“Christine explores legal options with clients to meet business needs and legal obligations.”","detail":"Chambers USA (2023)"},{"title":"“She is able to give practical advice which is solution-orientated.”","detail":"Chambers USA (2023)"},{"title":"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”","detail":" Chambers USA (2022)"},{"title":"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”","detail":"Chambers Global (2022)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions ","detail":"Chambers Global, USA (2012, 2018-2025)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions","detail":"Chambers USA, Nationwide (2010-2011, 2017-2025)"},{"title":"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”","detail":"Chambers USA (2018)"},{"title":"Top Rated International Lawyer","detail":"Super Lawyers, Washington, D.C."},{"title":"Recognized Practitioner","detail":"Legal 500 US"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1165},{"id":1165}]},"capability_group_id":2},"created_at":"2025-11-05T05:04:06.000Z","updated_at":"2025-11-05T05:04:06.000Z","searchable_text":"Savage{{ FIELD }}{:title=\u0026gt;\"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions\", :detail=\u0026gt;\"Legal 500 USA (2025)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Christine has a deep understanding of this area of law and gets all aspects.\\\"\", :detail=\u0026gt;\"Chambers USA, Nationwide (2025)\"}{{ FIELD }}{:title=\u0026gt;\"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“Christine explores legal options with clients to meet business needs and legal obligations.”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“She is able to give practical advice which is solution-orientated.”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”\", :detail=\u0026gt;\" Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”\", :detail=\u0026gt;\"Chambers Global (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions \", :detail=\u0026gt;\"Chambers Global, USA (2012, 2018-2025)\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions\", :detail=\u0026gt;\"Chambers USA, Nationwide (2010-2011, 2017-2025)\"}{{ FIELD }}{:title=\u0026gt;\"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”\", :detail=\u0026gt;\"Chambers USA (2018)\"}{{ FIELD }}{:title=\u0026gt;\"Top Rated International Lawyer\", :detail=\u0026gt;\"Super Lawyers, Washington, D.C.\"}{{ FIELD }}{:title=\u0026gt;\"Recognized Practitioner\", :detail=\u0026gt;\"Legal 500 US\"}{{ FIELD }}Assisted energy, infrastructure, defense, and biotechnology companies in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.{{ FIELD }}Represented several U.S. and non-U.S. aerospace and defense companies in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.{{ FIELD }}Representing companies in the FinTech industry with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.{{ FIELD }}Assisted in obtaining clearance by CFIUS for companies in sensitive sectors, including defense, critical technology, and critical infrastructure industries of foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.{{ FIELD }}Assisted numerous clients in the pharmaceutical, medical device and agricultural industries in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.{{ FIELD }}Christine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").\nChristine has over 25 years of experience helping clients handle their international trade regulatory, compliance, and investigation needs.  She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.  She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS.  \nChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings  and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.  She also represents clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for legislative and regulatory solutions to help advance their trade and investment goals.\nPreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.  In that role, she acted as counsel to the government in trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\nChristine was recommended by Legal 500 U.S. in the International Trade category. She is recognized by Chambers Global and Chambers U.S.A. in the International Trade: Export Controls \u0026amp; Economic Sanctions category. Partner Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions Legal 500 USA (2025) \"Christine has a deep understanding of this area of law and gets all aspects.\" Chambers USA, Nationwide (2025) “She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...” Chambers USA (2023) “Christine explores legal options with clients to meet business needs and legal obligations.” Chambers USA (2023) “She is able to give practical advice which is solution-orientated.” Chambers USA (2023) “Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”  Chambers USA (2022) “She is extremely effective and extraordinarily knowledgeable about export controls issues.” Chambers Global (2022) Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions  Chambers Global, USA (2012, 2018-2025) Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions Chambers USA, Nationwide (2010-2011, 2017-2025) “Exceptionally well versed in various trade regulations and has provided very insightful counsel...” Chambers USA (2018) Top Rated International Lawyer Super Lawyers, Washington, D.C. Recognized Practitioner Legal 500 US University of Michigan University of Michigan Law School Columbus School of Law, Catholic University of America Columbus School of Law, Catholic University of America U.S. Court of Appeals for the Federal Circuit U.S. Court of International Trade District of Columbia New York The District of Columbia Bar United States Court of Appeals for the Federal Circuit Court of International Trade American Bar Association, International Trade Section, Export Committee Assisted energy, infrastructure, defense, and biotechnology companies in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS. Represented several U.S. and non-U.S. aerospace and defense companies in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control. Representing companies in the FinTech industry with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues. Assisted in obtaining clearance by CFIUS for companies in sensitive sectors, including defense, critical technology, and critical infrastructure industries of foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government. Assisted numerous clients in the pharmaceutical, medical device and agricultural industries in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.","searchable_name":"Christine E. Savage","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442855,"version":1,"owner_type":"Person","owner_id":6047,"payload":{"bio":"\u003cp\u003eA former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento\u0026nbsp;with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).\u0026nbsp; The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.\u0026nbsp;\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg represents corporations under criminal and/or civil\u0026nbsp;investigation by Federal, state, and local prosecutors' offices.\u0026nbsp; He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.\u0026nbsp; Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.\u0026nbsp;\u0026nbsp;\u0026nbsp;The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the\u0026nbsp;twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.\u0026nbsp; \u0026nbsp;He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.\u0026nbsp;\u003c/p\u003e","slug":"greg-scott","email":"mscott@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":4,"guid":"4.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Scott","nick_name":"Greg","clerkships":[],"first_name":"McGregor","title_rank":9999,"updated_by":32,"law_schools":[{"id":2158,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1989-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento","detail":"Best Lawyers® in America (2023)"},{"title":"Recognized for Criminal Defense: White-Collar","detail":"Best Lawyers in America (2013-2023)"}],"linked_in_url":"https://www.linkedin.com/in/mcgregor-scott-9527ba21/","seodescription":null,"primary_title_id":155,"translated_fields":{"en":{"bio":"\u003cp\u003eA former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento\u0026nbsp;with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).\u0026nbsp; The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.\u0026nbsp;\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg represents corporations under criminal and/or civil\u0026nbsp;investigation by Federal, state, and local prosecutors' offices.\u0026nbsp; He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.\u0026nbsp; Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.\u0026nbsp;\u0026nbsp;\u0026nbsp;The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the\u0026nbsp;twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.\u0026nbsp; \u0026nbsp;He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.\u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento","detail":"Best Lawyers® in America (2023)"},{"title":"Recognized for Criminal Defense: White-Collar","detail":"Best Lawyers in America (2013-2023)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8858}]},"capability_group_id":2},"created_at":"2025-11-13T04:58:49.000Z","updated_at":"2025-11-13T04:58:49.000Z","searchable_text":"Scott{{ FIELD }}{:title=\u0026gt;\"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento\", :detail=\u0026gt;\"Best Lawyers® in America (2023)\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for Criminal Defense: White-Collar\", :detail=\u0026gt;\"Best Lawyers in America (2013-2023)\"}{{ FIELD }}A former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).  The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.  \nGreg represents corporations under criminal and/or civil investigation by Federal, state, and local prosecutors' offices.  He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.  Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.   The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.  \nGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.   He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.  Partner Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento Best Lawyers® in America (2023) Recognized for Criminal Defense: White-Collar Best Lawyers in America (2013-2023) Santa Clara University Santa Clara University School of Law University of California Hastings College of Law University of California Hastings College of Law California Federal Bar Association Sacramento County Bar Association","searchable_name":"McGregor Scott (Greg)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":442375,"version":1,"owner_type":"Person","owner_id":923,"payload":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","slug":"john-shakow","email":"jshakow@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":179}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":6,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Shakow","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"D.","name_suffix":"","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}],"linked_in_url":"https://www.linkedin.com/in/JohnShakow/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11649}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:46.000Z","updated_at":"2025-11-05T05:03:46.000Z","searchable_text":"Shakow{{ FIELD }}{:title=\u0026gt;\"“John is extremely strong and extremely client-focused.”\", :detail=\u0026gt;\"CHAMBERS USA, 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory\", :detail=\u0026gt;\"CHAMBERS USA, 2021, 2022, 2023 and 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Key Lawyer: 2021, 2022, 2023\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023\", :detail=\u0026gt;\"LMG Life Sciences\"}{{ FIELD }}{:title=\u0026gt;\"2016 Lifetime Achievement Award\", :detail=\u0026gt;\"Institute for International Research's Medicaid Drug Rebate Program\"}{{ FIELD }}{:title=\u0026gt;\"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018\", :detail=\u0026gt;\"Guide to Leading Life Sciences Firms and Attorneys in North America\"}{{ FIELD }}John Shakow focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.\nJohn has over 25 years' experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\nHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\nJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen dozens of substantial bona fide service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\nJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries. John D Shakow Partner “John is extremely strong and extremely client-focused.” CHAMBERS USA, 2022 “Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory CHAMBERS USA, 2021, 2022, 2023 and 2024 Recommended Key Lawyer: 2021, 2022, 2023 Legal 500 Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023 LMG Life Sciences 2016 Lifetime Achievement Award Institute for International Research's Medicaid Drug Rebate Program Life Sciences Star: Pricing and Reimbursement, 2012 to 2018 Guide to Leading Life Sciences Firms and Attorneys in North America Swarthmore College  University of Virginia University of Virginia School of Law U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of Virginia U.S. District Court for the Central District of Illinois U.S. District Court for the District of Columbia District of Columbia Virginia District of Columbia Bar State Bar of Virginia","searchable_name":"John D. Shakow","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":427262,"version":1,"owner_type":"Person","owner_id":6596,"payload":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","slug":"jeffrey-shapiro","email":"jshapiro@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":5,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Shapiro","nick_name":"Jeffrey","clerkships":[],"first_name":"Jeffrey","title_rank":9999,"updated_by":35,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"1986-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11031}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:28.000Z","updated_at":"2025-05-26T04:59:28.000Z","searchable_text":"Shapiro{{ FIELD }}{:title=\u0026gt;\"Life Sciences Key Lawyer\", :detail=\u0026gt;\"The Legal 500 (2024)\"}{{ FIELD }}{:title=\u0026gt;\"Life Science Star\", :detail=\u0026gt;\"LMG Life Sciences, 2012 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"DC Super Lawyer\", :detail=\u0026gt;\"Super Lawyers, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"The International Who’s Who of Business Lawyers – Life Sciences\", :detail=\u0026gt;\"Who’s Who Legal, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"Nominee for Regulatory Attorney of the Year\", :detail=\u0026gt;\"LMG Life Sciences, 2017\"}{{ FIELD }}Jeff has 30 years’ experience in US medical device law and regulation.  He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.  He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA’s requests for information and data.  When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.  His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.  Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA’s regulation of combination products (e.g., drug-device combinations).\nJeff is a national authority on FDA’s regulation of medical devices, combination products, and HCT/Ps.  He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA’s regulation of medical devices.\nHe is a past member of the Editorial Advisory Board for both MDDI and Update magazines, co-editor of two textbooks, Promotion of Biomedical Products (Food and Drug Law Institute, 2006) and Combination Products, How to Develop the Optimal Strategic Path for Approval (FDA News 2005).  He has contributed chapters to several textbooks, including Medical Devices Law and Regulation Answer Book (Practising Law Institute 2023 ed.).\nJeff was a Lecturer and Fischell Literati teaching the University of Maryland’s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute. Partner Life Sciences Key Lawyer The Legal 500 (2024) Life Science Star LMG Life Sciences, 2012 – 2023 DC Super Lawyer Super Lawyers, 2014 – 2023 The International Who’s Who of Business Lawyers – Life Sciences Who’s Who Legal, 2014 – 2023 Nominee for Regulatory Attorney of the Year LMG Life Sciences, 2017 Brown University  Harvard University Harvard Law School District of Columbia","searchable_name":"Jeffrey K. Shapiro","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":447659,"version":1,"owner_type":"Person","owner_id":6445,"payload":{"bio":"\u003cp\u003eRichard Sharpe is a partner in King \u0026amp; Spalding's Singapore office and a member of the firm's Special Matters and Government Investigations Group.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRichard assists multinational clients across the Asia-Pacific and Middle East region with a variety of business-related criminal matters and cross-border investigations, including anti-bribery and corruption, anti-money laundering, international sanctions, cyber-crime and fraud.\u003c/p\u003e\n\u003cp\u003eAn England and Wales barrister, and a\u0026nbsp;Hong Kong-qualified solicitor, Richard\u0026rsquo;s experience includes representing businesses and individuals under investigation by various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Bureau of Industry and Security, the U.K Serious Fraud Office, the Hong Kong Monetary Authority, the Hong Kong Securities and Futures Commission, and the Hong Kong Independent Commission Against Corruption.\u003c/p\u003e\n\u003cp\u003eIn addition, Richard has significant experience of conducting complex civil litigation and arbitrations arising from fraud and other criminal misconduct, as well as obtaining supporting ancillary relief. He also advises global companies on investment-related international risk and the design and implementation of compliance programs.\u003c/p\u003e\n\u003cp\u003eRichard was a barrister in England and Wales for the first 11 years of practice, focusing on the prosecution and defence of complex business crime and civil asset recovery, before relocating to Hong Kong in 2013. Richard has been recognised in\u0026nbsp;\u003cem\u003eChambers Global and Asia-Pacific\u003c/em\u003e\u0026nbsp;in the category of Corporate Investigations / Anti-Corruption: International since 2020.\u003c/p\u003e\n\u003cp\u003eIn Chambers Asia-Pacific 2024, clients note \"Richard is great, super responsive, fully understands commercial dynamics\u0026nbsp;and what clients are looking to achieve\", and \"Richard is a great communicator, and\u0026nbsp;can distil very complex regulatory matters into manageable and clear advice\".\u003c/p\u003e\n\u003cp\u003eIn a\u0026nbsp;\u003cem\u003eChambers Global\u003c/em\u003e\u0026nbsp;interview, clients describe Richard as \u0026ldquo;a total professional\u0026rdquo; who \u0026ldquo;understands the region well.\u0026rdquo;, and notes that he advises global organisations on a range of compliance mandates including anti-corruption, anti-money laundering and trade controls.\u003c/p\u003e\n\u003cp\u003eClients further noted \u0026ldquo;Richard Sharpe receives praise for his ability to handle complex regulatory investigations and is singled out for his expert knowledge of the UK Bribery Act. Sources note that his experience acting in court as a barrister in the UK enables him to \u0026lsquo;appreciate the nuances of how the prosecutors will think\u0026rsquo; and gives him \u0026lsquo;a great edge\u0026rsquo;. Clients refer to him as a \u0026lsquo;star performer,\u0026rsquo; citing his \u0026lsquo;excellent advice\u0026rsquo; and \u0026lsquo;strong work product\u0026rsquo; as key strengths.\u0026rdquo; Clients describe him as a good guy who is making an impact\u0026rdquo;\u0026nbsp;note: \u0026ldquo;he knows what he is doing.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;Hong Kong: \u0026ldquo;Richard Sharpe is qualified as a barrister in London and solicitor in Hong Kong, giving him a \u0026lsquo;unique perspective to analyze complex regulatory/white-collar issues\u003c/p\u003e","slug":"richard-sharpe","email":"rsharpe@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eArbitration and litigation\u003cbr /\u003e\u003c/strong\u003eActed for\u0026nbsp;\u003cstrong\u003ean international private equity fund\u003c/strong\u003e\u0026nbsp;in Cayman law governed HKIAC arbitration proceedings (seated in Hong Kong), in connection with a claim against a limited partner of the fund for approximately USD 1bn, for breach of confidentiality. This was one of the first ever significant hearings in the HKIAC, conducted via Zoom.\u003c/p\u003e","\u003cp\u003eActed in\u0026nbsp;\u003cstrong\u003eICC arbitration proceedings\u003c/strong\u003e\u0026nbsp;(seated in New York), and ancillary Hong Kong High Court proceedings in connection with a shareholders\u0026rsquo; dispute in Hong Kong, arising from U.S. Chapter 11 proceedings.\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ea multinational professional services firm\u003c/strong\u003e\u0026nbsp;in Hong Kong High Court contempt of court proceedings, arising from a dispute over the enforceability of inter-jurisdictional disclosure obligations.\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ean international private equity fund\u003c/strong\u003e\u0026nbsp;in CIETAC arbitration proceedings (seated in Beijing) in connection with claims of fraud arising from the purchase of a business in the PRC (value in excess of USD 250m) (including conducting the advocacy in the High Court of Hong Kong to freeze more than USD 250m Worldwide).\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003eon international trade finance fraud\u003c/strong\u003e\u0026nbsp;claims approaching USD 1bn arising out of a multi-jurisdictional insolvency.\u003c/p\u003e","\u003cp\u003eActed for the\u0026nbsp;\u003cstrong\u003eprivate equity arm\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003eof an international bank\u003c/strong\u003e\u0026nbsp;in SIAC arbitration proceedings (seated in Singapore) in connection with claims of fraud arising from a direct equity investment in an Indian movie company (value in excess of USD 60m).\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ean international bank\u003c/strong\u003e\u0026nbsp;in three LCIA arbitration proceedings (seated in London) with a combined value of USD 85m, against a Russian-Mongolian SOE and a Mongolian conglomerate in connection with the bank's investment in one of the World's largest copper mines, and fraud arising from the related structured facilities and security arrangements. Also acted in the connected England and Wales High Court litigation relating to separate facilities worth USD 60m.\u003c/p\u003e","\u003cp\u003eExtensive advocacy experience of obtaining ancillary relief (in particular Mareva relief) in support of international arbitrations and commercial litigation in Hong Kong.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eInvestigations\u003cbr /\u003e\u003c/strong\u003eConducted a wide ranging investigation into FCPA and insider trading allegations in the China real estate business of a New York listed, public company.\u003c/p\u003e","\u003cp\u003eRepresented the portfolio company of a US private equity company in the first negotiated settlement with the Hong Kong Competition Commission, for cartelling.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation into multi-million US dollar employee fraud in the Hong Kong offices of a SFC and SEC regulated fund.\u003c/p\u003e","\u003cp\u003eConducted an audit committee investigation into fraudulent accounting allegations in a global energy services platform in the Middle East, ultimately owned by a New York listed, public company.\u003c/p\u003e","\u003cp\u003eActed in a 5 year, wide ranging internal investigation and representation of a Chinese telecommunications company (ZTE) in a significant export controls and economic sanctions investigation by the U.S. Departments of Justice, Commerce (BIS), and Treasury (OFAC). This culminated in the largest ever settlement for an export controls violation (USD 1.2bn).\u003c/p\u003e","\u003cp\u003eActed in the representation of the Hong Kong branch of a PRC bank under investigation by the HKMA/ICAC for anti-corruption offences, including being scrambled to the dawn raid on the premises by the ICAC, following which the branch's CEO and 2 other staff members were arrested and prosecuted.\u003c/p\u003e","\u003cp\u003eActed in the representation of an international bank under HKMA regulatory investigation into a widespread banking fraud perpetrated by a member of retail staff (who was arrested and prosecuted), as well as conducting the associated litigation (conducted the advocacy in Hong Kong to freeze USD 26m).\u003c/p\u003e","\u003cp\u003eActed in a regulatory investigation into the theft by staff of a global re-insurer of commercially sensitive IP from a key rival. The case involved interactions with the HKCIB, the UK Financial Conduct Authority and the ICAC, as well as litigation arising.\u003c/p\u003e","\u003cp\u003eActed in an anti-corruption investigation into a MNC's practices in Hong Kong and the PRC, from a FCPA, UKBA, Hong Kong, and PRC law perspective.\u003c/p\u003e","\u003cp\u003eActed in the representation of an international bank under investigation by the SFC into financial services misselling.\u003c/p\u003e","\u003cp\u003eMultiple representations of individuals employed by financial institutions and MNCs under investigation by the ICAC.\u003c/p\u003e","\u003cp\u003eDefence of financial institution clients criminally prosecuted by Customs and Excise for offences under the Import Ordinance (including conducting Hong Kong Court advocacy) relating to technology imports.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":14,"guid":"14.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":110,"guid":"110.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":803,"guid":"803.smart_tags","index":8,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":9,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Sharpe","nick_name":"Richard","clerkships":[],"first_name":"Richard","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Richard Sharpe recognised as Litigation Star in Singapore","detail":"BENCHMARK LITIGATION ASIA PACIFIC 2026"},{"title":"Richard Sharpe – Recommended Lawyer","detail":"LEGAL 500 ASIA-PACIFIC, WHITE-COLLAR CRIME - FOREIGN FIRMS, SINGAPORE 2026"},{"title":"\"Richard Sharpe is a real professional with a keen understanding of his clients' objectives.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard actively works to find compliant solutions that facilitate their deals. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard is a very strong individual who is able to expertly lead you through a matter. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard has a very calm demeanour and is very approachable. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"\"Richard always goes the extra mile and is a pleasure to work with.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard can cut through all the information with such success.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard is someone you can give a matter to and trust that he'll take expert care of it.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"“Working with Richard makes complex matters seem easy.” -  Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard can distil complex matters into manageable and clear advice.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard knows the issues we face in the region and provides practical advice.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard fully understands what clients are looking to achieve.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard works with the deal team to achieve the best solution.\" - Corporate Investigation / Anti-Corruption ","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"Richard was named as an \"up and coming lawyer\" ","detail":"CHAMBERS ASIA-PACIFIC 2020, 2021, 2022 AND 2023"},{"title":"Richard is \"a total professional\" who \"understands the region well.\"","detail":"CHAMBERS GLOBAL 2020 "},{"title":"Clients refer to Richard as a 'star performer,' citing his 'excellent advice' and 'strong work product' as key strengths ","detail":"CHAMBERS ASIA-PACIFIC 2020 "},{"title":"Richard can \"appreciate the nuances of how the prosecutors will think\" giving him \"a great edge.\"","detail":"CHAMBERS ASIA-PACIFIC 2020 "}],"linked_in_url":"https://www.linkedin.com/in/richard-sharpe-9473b37b/?originalSubdomain=hk","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRichard Sharpe is a partner in King \u0026amp; Spalding's Singapore office and a member of the firm's Special Matters and Government Investigations Group.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRichard assists multinational clients across the Asia-Pacific and Middle East region with a variety of business-related criminal matters and cross-border investigations, including anti-bribery and corruption, anti-money laundering, international sanctions, cyber-crime and fraud.\u003c/p\u003e\n\u003cp\u003eAn England and Wales barrister, and a\u0026nbsp;Hong Kong-qualified solicitor, Richard\u0026rsquo;s experience includes representing businesses and individuals under investigation by various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Bureau of Industry and Security, the U.K Serious Fraud Office, the Hong Kong Monetary Authority, the Hong Kong Securities and Futures Commission, and the Hong Kong Independent Commission Against Corruption.\u003c/p\u003e\n\u003cp\u003eIn addition, Richard has significant experience of conducting complex civil litigation and arbitrations arising from fraud and other criminal misconduct, as well as obtaining supporting ancillary relief. He also advises global companies on investment-related international risk and the design and implementation of compliance programs.\u003c/p\u003e\n\u003cp\u003eRichard was a barrister in England and Wales for the first 11 years of practice, focusing on the prosecution and defence of complex business crime and civil asset recovery, before relocating to Hong Kong in 2013. Richard has been recognised in\u0026nbsp;\u003cem\u003eChambers Global and Asia-Pacific\u003c/em\u003e\u0026nbsp;in the category of Corporate Investigations / Anti-Corruption: International since 2020.\u003c/p\u003e\n\u003cp\u003eIn Chambers Asia-Pacific 2024, clients note \"Richard is great, super responsive, fully understands commercial dynamics\u0026nbsp;and what clients are looking to achieve\", and \"Richard is a great communicator, and\u0026nbsp;can distil very complex regulatory matters into manageable and clear advice\".\u003c/p\u003e\n\u003cp\u003eIn a\u0026nbsp;\u003cem\u003eChambers Global\u003c/em\u003e\u0026nbsp;interview, clients describe Richard as \u0026ldquo;a total professional\u0026rdquo; who \u0026ldquo;understands the region well.\u0026rdquo;, and notes that he advises global organisations on a range of compliance mandates including anti-corruption, anti-money laundering and trade controls.\u003c/p\u003e\n\u003cp\u003eClients further noted \u0026ldquo;Richard Sharpe receives praise for his ability to handle complex regulatory investigations and is singled out for his expert knowledge of the UK Bribery Act. Sources note that his experience acting in court as a barrister in the UK enables him to \u0026lsquo;appreciate the nuances of how the prosecutors will think\u0026rsquo; and gives him \u0026lsquo;a great edge\u0026rsquo;. Clients refer to him as a \u0026lsquo;star performer,\u0026rsquo; citing his \u0026lsquo;excellent advice\u0026rsquo; and \u0026lsquo;strong work product\u0026rsquo; as key strengths.\u0026rdquo; Clients describe him as a good guy who is making an impact\u0026rdquo;\u0026nbsp;note: \u0026ldquo;he knows what he is doing.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;Hong Kong: \u0026ldquo;Richard Sharpe is qualified as a barrister in London and solicitor in Hong Kong, giving him a \u0026lsquo;unique perspective to analyze complex regulatory/white-collar issues\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eArbitration and litigation\u003cbr /\u003e\u003c/strong\u003eActed for\u0026nbsp;\u003cstrong\u003ean international private equity fund\u003c/strong\u003e\u0026nbsp;in Cayman law governed HKIAC arbitration proceedings (seated in Hong Kong), in connection with a claim against a limited partner of the fund for approximately USD 1bn, for breach of confidentiality. This was one of the first ever significant hearings in the HKIAC, conducted via Zoom.\u003c/p\u003e","\u003cp\u003eActed in\u0026nbsp;\u003cstrong\u003eICC arbitration proceedings\u003c/strong\u003e\u0026nbsp;(seated in New York), and ancillary Hong Kong High Court proceedings in connection with a shareholders\u0026rsquo; dispute in Hong Kong, arising from U.S. Chapter 11 proceedings.\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ea multinational professional services firm\u003c/strong\u003e\u0026nbsp;in Hong Kong High Court contempt of court proceedings, arising from a dispute over the enforceability of inter-jurisdictional disclosure obligations.\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ean international private equity fund\u003c/strong\u003e\u0026nbsp;in CIETAC arbitration proceedings (seated in Beijing) in connection with claims of fraud arising from the purchase of a business in the PRC (value in excess of USD 250m) (including conducting the advocacy in the High Court of Hong Kong to freeze more than USD 250m Worldwide).\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003eon international trade finance fraud\u003c/strong\u003e\u0026nbsp;claims approaching USD 1bn arising out of a multi-jurisdictional insolvency.\u003c/p\u003e","\u003cp\u003eActed for the\u0026nbsp;\u003cstrong\u003eprivate equity arm\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003eof an international bank\u003c/strong\u003e\u0026nbsp;in SIAC arbitration proceedings (seated in Singapore) in connection with claims of fraud arising from a direct equity investment in an Indian movie company (value in excess of USD 60m).\u003c/p\u003e","\u003cp\u003eActed for\u0026nbsp;\u003cstrong\u003ean international bank\u003c/strong\u003e\u0026nbsp;in three LCIA arbitration proceedings (seated in London) with a combined value of USD 85m, against a Russian-Mongolian SOE and a Mongolian conglomerate in connection with the bank's investment in one of the World's largest copper mines, and fraud arising from the related structured facilities and security arrangements. Also acted in the connected England and Wales High Court litigation relating to separate facilities worth USD 60m.\u003c/p\u003e","\u003cp\u003eExtensive advocacy experience of obtaining ancillary relief (in particular Mareva relief) in support of international arbitrations and commercial litigation in Hong Kong.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eInvestigations\u003cbr /\u003e\u003c/strong\u003eConducted a wide ranging investigation into FCPA and insider trading allegations in the China real estate business of a New York listed, public company.\u003c/p\u003e","\u003cp\u003eRepresented the portfolio company of a US private equity company in the first negotiated settlement with the Hong Kong Competition Commission, for cartelling.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation into multi-million US dollar employee fraud in the Hong Kong offices of a SFC and SEC regulated fund.\u003c/p\u003e","\u003cp\u003eConducted an audit committee investigation into fraudulent accounting allegations in a global energy services platform in the Middle East, ultimately owned by a New York listed, public company.\u003c/p\u003e","\u003cp\u003eActed in a 5 year, wide ranging internal investigation and representation of a Chinese telecommunications company (ZTE) in a significant export controls and economic sanctions investigation by the U.S. Departments of Justice, Commerce (BIS), and Treasury (OFAC). This culminated in the largest ever settlement for an export controls violation (USD 1.2bn).\u003c/p\u003e","\u003cp\u003eActed in the representation of the Hong Kong branch of a PRC bank under investigation by the HKMA/ICAC for anti-corruption offences, including being scrambled to the dawn raid on the premises by the ICAC, following which the branch's CEO and 2 other staff members were arrested and prosecuted.\u003c/p\u003e","\u003cp\u003eActed in the representation of an international bank under HKMA regulatory investigation into a widespread banking fraud perpetrated by a member of retail staff (who was arrested and prosecuted), as well as conducting the associated litigation (conducted the advocacy in Hong Kong to freeze USD 26m).\u003c/p\u003e","\u003cp\u003eActed in a regulatory investigation into the theft by staff of a global re-insurer of commercially sensitive IP from a key rival. The case involved interactions with the HKCIB, the UK Financial Conduct Authority and the ICAC, as well as litigation arising.\u003c/p\u003e","\u003cp\u003eActed in an anti-corruption investigation into a MNC's practices in Hong Kong and the PRC, from a FCPA, UKBA, Hong Kong, and PRC law perspective.\u003c/p\u003e","\u003cp\u003eActed in the representation of an international bank under investigation by the SFC into financial services misselling.\u003c/p\u003e","\u003cp\u003eMultiple representations of individuals employed by financial institutions and MNCs under investigation by the ICAC.\u003c/p\u003e","\u003cp\u003eDefence of financial institution clients criminally prosecuted by Customs and Excise for offences under the Import Ordinance (including conducting Hong Kong Court advocacy) relating to technology imports.\u003c/p\u003e"],"recognitions":[{"title":"Richard Sharpe recognised as Litigation Star in Singapore","detail":"BENCHMARK LITIGATION ASIA PACIFIC 2026"},{"title":"Richard Sharpe – Recommended Lawyer","detail":"LEGAL 500 ASIA-PACIFIC, WHITE-COLLAR CRIME - FOREIGN FIRMS, SINGAPORE 2026"},{"title":"\"Richard Sharpe is a real professional with a keen understanding of his clients' objectives.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard actively works to find compliant solutions that facilitate their deals. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard is a very strong individual who is able to expertly lead you through a matter. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"Richard has a very calm demeanour and is very approachable. - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026"},{"title":"\"Richard always goes the extra mile and is a pleasure to work with.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard can cut through all the information with such success.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard is someone you can give a matter to and trust that he'll take expert care of it.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"“Working with Richard makes complex matters seem easy.” -  Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 "},{"title":"\"Richard can distil complex matters into manageable and clear advice.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard knows the issues we face in the region and provides practical advice.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard fully understands what clients are looking to achieve.\" - Corporate Investigation / Anti-Corruption","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"\"Richard works with the deal team to achieve the best solution.\" - Corporate Investigation / Anti-Corruption ","detail":"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 "},{"title":"Richard was named as an \"up and coming lawyer\" ","detail":"CHAMBERS ASIA-PACIFIC 2020, 2021, 2022 AND 2023"},{"title":"Richard is \"a total professional\" who \"understands the region well.\"","detail":"CHAMBERS GLOBAL 2020 "},{"title":"Clients refer to Richard as a 'star performer,' citing his 'excellent advice' and 'strong work product' as key strengths ","detail":"CHAMBERS ASIA-PACIFIC 2020 "},{"title":"Richard can \"appreciate the nuances of how the prosecutors will think\" giving him \"a great edge.\"","detail":"CHAMBERS ASIA-PACIFIC 2020 "}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10889}]},"capability_group_id":2},"created_at":"2026-04-21T14:51:19.000Z","updated_at":"2026-04-21T14:51:19.000Z","searchable_text":"Sharpe{{ FIELD }}{:title=\u0026gt;\"Richard Sharpe recognised as Litigation Star in Singapore\", :detail=\u0026gt;\"BENCHMARK LITIGATION ASIA PACIFIC 2026\"}{{ FIELD }}{:title=\u0026gt;\"Richard Sharpe – Recommended Lawyer\", :detail=\u0026gt;\"LEGAL 500 ASIA-PACIFIC, WHITE-COLLAR CRIME - FOREIGN FIRMS, SINGAPORE 2026\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard Sharpe is a real professional with a keen understanding of his clients' objectives.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026\"}{{ FIELD }}{:title=\u0026gt;\"Richard actively works to find compliant solutions that facilitate their deals. - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026\"}{{ FIELD }}{:title=\u0026gt;\"Richard is a very strong individual who is able to expertly lead you through a matter. - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026\"}{{ FIELD }}{:title=\u0026gt;\"Richard has a very calm demeanour and is very approachable. - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, SINGAPORE 2026\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard always goes the extra mile and is a pleasure to work with.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard can cut through all the information with such success.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard is someone you can give a matter to and trust that he'll take expert care of it.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 \"}{{ FIELD }}{:title=\u0026gt;\"“Working with Richard makes complex matters seem easy.” -  Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard can distil complex matters into manageable and clear advice.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard knows the issues we face in the region and provides practical advice.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard fully understands what clients are looking to achieve.\\\" - Corporate Investigation / Anti-Corruption\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 \"}{{ FIELD }}{:title=\u0026gt;\"\\\"Richard works with the deal team to achieve the best solution.\\\" - Corporate Investigation / Anti-Corruption \", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024 \"}{{ FIELD }}{:title=\u0026gt;\"Richard was named as an \\\"up and coming lawyer\\\" \", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC 2020, 2021, 2022 AND 2023\"}{{ FIELD }}{:title=\u0026gt;\"Richard is \\\"a total professional\\\" who \\\"understands the region well.\\\"\", :detail=\u0026gt;\"CHAMBERS GLOBAL 2020 \"}{{ FIELD }}{:title=\u0026gt;\"Clients refer to Richard as a 'star performer,' citing his 'excellent advice' and 'strong work product' as key strengths \", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC 2020 \"}{{ FIELD }}{:title=\u0026gt;\"Richard can \\\"appreciate the nuances of how the prosecutors will think\\\" giving him \\\"a great edge.\\\"\", :detail=\u0026gt;\"CHAMBERS ASIA-PACIFIC 2020 \"}{{ FIELD }}Arbitration and litigationActed for an international private equity fund in Cayman law governed HKIAC arbitration proceedings (seated in Hong Kong), in connection with a claim against a limited partner of the fund for approximately USD 1bn, for breach of confidentiality. This was one of the first ever significant hearings in the HKIAC, conducted via Zoom.{{ FIELD }}Acted in ICC arbitration proceedings (seated in New York), and ancillary Hong Kong High Court proceedings in connection with a shareholders’ dispute in Hong Kong, arising from U.S. Chapter 11 proceedings.{{ FIELD }}Acted for a multinational professional services firm in Hong Kong High Court contempt of court proceedings, arising from a dispute over the enforceability of inter-jurisdictional disclosure obligations.{{ FIELD }}Acted for an international private equity fund in CIETAC arbitration proceedings (seated in Beijing) in connection with claims of fraud arising from the purchase of a business in the PRC (value in excess of USD 250m) (including conducting the advocacy in the High Court of Hong Kong to freeze more than USD 250m Worldwide).{{ FIELD }}Advised on international trade finance fraud claims approaching USD 1bn arising out of a multi-jurisdictional insolvency.{{ FIELD }}Acted for the private equity arm of an international bank in SIAC arbitration proceedings (seated in Singapore) in connection with claims of fraud arising from a direct equity investment in an Indian movie company (value in excess of USD 60m).{{ FIELD }}Acted for an international bank in three LCIA arbitration proceedings (seated in London) with a combined value of USD 85m, against a Russian-Mongolian SOE and a Mongolian conglomerate in connection with the bank's investment in one of the World's largest copper mines, and fraud arising from the related structured facilities and security arrangements. Also acted in the connected England and Wales High Court litigation relating to separate facilities worth USD 60m.{{ FIELD }}Extensive advocacy experience of obtaining ancillary relief (in particular Mareva relief) in support of international arbitrations and commercial litigation in Hong Kong.{{ FIELD }}InvestigationsConducted a wide ranging investigation into FCPA and insider trading allegations in the China real estate business of a New York listed, public company.{{ FIELD }}Represented the portfolio company of a US private equity company in the first negotiated settlement with the Hong Kong Competition Commission, for cartelling.{{ FIELD }}Conducted an internal investigation into multi-million US dollar employee fraud in the Hong Kong offices of a SFC and SEC regulated fund.{{ FIELD }}Conducted an audit committee investigation into fraudulent accounting allegations in a global energy services platform in the Middle East, ultimately owned by a New York listed, public company.{{ FIELD }}Acted in a 5 year, wide ranging internal investigation and representation of a Chinese telecommunications company (ZTE) in a significant export controls and economic sanctions investigation by the U.S. Departments of Justice, Commerce (BIS), and Treasury (OFAC). This culminated in the largest ever settlement for an export controls violation (USD 1.2bn).{{ FIELD }}Acted in the representation of the Hong Kong branch of a PRC bank under investigation by the HKMA/ICAC for anti-corruption offences, including being scrambled to the dawn raid on the premises by the ICAC, following which the branch's CEO and 2 other staff members were arrested and prosecuted.{{ FIELD }}Acted in the representation of an international bank under HKMA regulatory investigation into a widespread banking fraud perpetrated by a member of retail staff (who was arrested and prosecuted), as well as conducting the associated litigation (conducted the advocacy in Hong Kong to freeze USD 26m).{{ FIELD }}Acted in a regulatory investigation into the theft by staff of a global re-insurer of commercially sensitive IP from a key rival. The case involved interactions with the HKCIB, the UK Financial Conduct Authority and the ICAC, as well as litigation arising.{{ FIELD }}Acted in an anti-corruption investigation into a MNC's practices in Hong Kong and the PRC, from a FCPA, UKBA, Hong Kong, and PRC law perspective.{{ FIELD }}Acted in the representation of an international bank under investigation by the SFC into financial services misselling.{{ FIELD }}Multiple representations of individuals employed by financial institutions and MNCs under investigation by the ICAC.{{ FIELD }}Defence of financial institution clients criminally prosecuted by Customs and Excise for offences under the Import Ordinance (including conducting Hong Kong Court advocacy) relating to technology imports.{{ FIELD }}Richard Sharpe is a partner in King \u0026amp; Spalding's Singapore office and a member of the firm's Special Matters and Government Investigations Group.\nRichard assists multinational clients across the Asia-Pacific and Middle East region with a variety of business-related criminal matters and cross-border investigations, including anti-bribery and corruption, anti-money laundering, international sanctions, cyber-crime and fraud.\nAn England and Wales barrister, and a Hong Kong-qualified solicitor, Richard’s experience includes representing businesses and individuals under investigation by various international regulators, including the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Office of Foreign Assets Control, the U.S. Bureau of Industry and Security, the U.K Serious Fraud Office, the Hong Kong Monetary Authority, the Hong Kong Securities and Futures Commission, and the Hong Kong Independent Commission Against Corruption.\nIn addition, Richard has significant experience of conducting complex civil litigation and arbitrations arising from fraud and other criminal misconduct, as well as obtaining supporting ancillary relief. He also advises global companies on investment-related international risk and the design and implementation of compliance programs.\nRichard was a barrister in England and Wales for the first 11 years of practice, focusing on the prosecution and defence of complex business crime and civil asset recovery, before relocating to Hong Kong in 2013. Richard has been recognised in Chambers Global and Asia-Pacific in the category of Corporate Investigations / Anti-Corruption: International since 2020.\nIn Chambers Asia-Pacific 2024, clients note \"Richard is great, super responsive, fully understands commercial dynamics and what clients are looking to achieve\", and \"Richard is a great communicator, and can distil very complex regulatory matters into manageable and clear advice\".\nIn a Chambers Global interview, clients describe Richard as “a total professional” who “understands the region well.”, and notes that he advises global organisations on a range of compliance mandates including anti-corruption, anti-money laundering and trade controls.\nClients further noted “Richard Sharpe receives praise for his ability to handle complex regulatory investigations and is singled out for his expert knowledge of the UK Bribery Act. Sources note that his experience acting in court as a barrister in the UK enables him to ‘appreciate the nuances of how the prosecutors will think’ and gives him ‘a great edge’. Clients refer to him as a ‘star performer,’ citing his ‘excellent advice’ and ‘strong work product’ as key strengths.” Clients describe him as a good guy who is making an impact” note: “he knows what he is doing.”\nLegal 500 Hong Kong: “Richard Sharpe is qualified as a barrister in London and solicitor in Hong Kong, giving him a ‘unique perspective to analyze complex regulatory/white-collar issues Partner Richard Sharpe recognised as Litigation Star in Singapore BENCHMARK LITIGATION ASIA PACIFIC 2026 Richard Sharpe – Recommended Lawyer LEGAL 500 ASIA-PACIFIC, WHITE-COLLAR CRIME - FOREIGN FIRMS, SINGAPORE 2026 \"Richard Sharpe is a real professional with a keen understanding of his clients' objectives.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, SINGAPORE 2026 Richard actively works to find compliant solutions that facilitate their deals. - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, SINGAPORE 2026 Richard is a very strong individual who is able to expertly lead you through a matter. - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, SINGAPORE 2026 Richard has a very calm demeanour and is very approachable. - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, SINGAPORE 2026 \"Richard always goes the extra mile and is a pleasure to work with.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025  \"Richard can cut through all the information with such success.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025  \"Richard is someone you can give a matter to and trust that he'll take expert care of it.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025  “Working with Richard makes complex matters seem easy.” -  Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2025  \"Richard can distil complex matters into manageable and clear advice.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024  \"Richard knows the issues we face in the region and provides practical advice.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024  \"Richard fully understands what clients are looking to achieve.\" - Corporate Investigation / Anti-Corruption CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024  \"Richard works with the deal team to achieve the best solution.\" - Corporate Investigation / Anti-Corruption  CHAMBERS ASIA-PACIFIC, INTERNATIONAL, SINGAPORE 2024  Richard was named as an \"up and coming lawyer\"  CHAMBERS ASIA-PACIFIC 2020, 2021, 2022 AND 2023 Richard is \"a total professional\" who \"understands the region well.\" CHAMBERS GLOBAL 2020  Clients refer to Richard as a 'star performer,' citing his 'excellent advice' and 'strong work product' as key strengths  CHAMBERS ASIA-PACIFIC 2020  Richard can \"appreciate the nuances of how the prosecutors will think\" giving him \"a great edge.\" CHAMBERS ASIA-PACIFIC 2020  Inns of Court School of Law, UK  Oxford University, UK  England and Wales Hong Kong Arbitration and litigationActed for an international private equity fund in Cayman law governed HKIAC arbitration proceedings (seated in Hong Kong), in connection with a claim against a limited partner of the fund for approximately USD 1bn, for breach of confidentiality. This was one of the first ever significant hearings in the HKIAC, conducted via Zoom. Acted in ICC arbitration proceedings (seated in New York), and ancillary Hong Kong High Court proceedings in connection with a shareholders’ dispute in Hong Kong, arising from U.S. Chapter 11 proceedings. Acted for a multinational professional services firm in Hong Kong High Court contempt of court proceedings, arising from a dispute over the enforceability of inter-jurisdictional disclosure obligations. Acted for an international private equity fund in CIETAC arbitration proceedings (seated in Beijing) in connection with claims of fraud arising from the purchase of a business in the PRC (value in excess of USD 250m) (including conducting the advocacy in the High Court of Hong Kong to freeze more than USD 250m Worldwide). Advised on international trade finance fraud claims approaching USD 1bn arising out of a multi-jurisdictional insolvency. Acted for the private equity arm of an international bank in SIAC arbitration proceedings (seated in Singapore) in connection with claims of fraud arising from a direct equity investment in an Indian movie company (value in excess of USD 60m). Acted for an international bank in three LCIA arbitration proceedings (seated in London) with a combined value of USD 85m, against a Russian-Mongolian SOE and a Mongolian conglomerate in connection with the bank's investment in one of the World's largest copper mines, and fraud arising from the related structured facilities and security arrangements. Also acted in the connected England and Wales High Court litigation relating to separate facilities worth USD 60m. Extensive advocacy experience of obtaining ancillary relief (in particular Mareva relief) in support of international arbitrations and commercial litigation in Hong Kong. InvestigationsConducted a wide ranging investigation into FCPA and insider trading allegations in the China real estate business of a New York listed, public company. Represented the portfolio company of a US private equity company in the first negotiated settlement with the Hong Kong Competition Commission, for cartelling. Conducted an internal investigation into multi-million US dollar employee fraud in the Hong Kong offices of a SFC and SEC regulated fund. Conducted an audit committee investigation into fraudulent accounting allegations in a global energy services platform in the Middle East, ultimately owned by a New York listed, public company. Acted in a 5 year, wide ranging internal investigation and representation of a Chinese telecommunications company (ZTE) in a significant export controls and economic sanctions investigation by the U.S. Departments of Justice, Commerce (BIS), and Treasury (OFAC). This culminated in the largest ever settlement for an export controls violation (USD 1.2bn). Acted in the representation of the Hong Kong branch of a PRC bank under investigation by the HKMA/ICAC for anti-corruption offences, including being scrambled to the dawn raid on the premises by the ICAC, following which the branch's CEO and 2 other staff members were arrested and prosecuted. Acted in the representation of an international bank under HKMA regulatory investigation into a widespread banking fraud perpetrated by a member of retail staff (who was arrested and prosecuted), as well as conducting the associated litigation (conducted the advocacy in Hong Kong to freeze USD 26m). Acted in a regulatory investigation into the theft by staff of a global re-insurer of commercially sensitive IP from a key rival. The case involved interactions with the HKCIB, the UK Financial Conduct Authority and the ICAC, as well as litigation arising. Acted in an anti-corruption investigation into a MNC's practices in Hong Kong and the PRC, from a FCPA, UKBA, Hong Kong, and PRC law perspective. Acted in the representation of an international bank under investigation by the SFC into financial services misselling. Multiple representations of individuals employed by financial institutions and MNCs under investigation by the ICAC. Defence of financial institution clients criminally prosecuted by Customs and Excise for offences under the Import Ordinance (including conducting Hong Kong Court advocacy) relating to technology imports.","searchable_name":"Richard Sharpe","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444834,"version":1,"owner_type":"Person","owner_id":2559,"payload":{"bio":"\u003cp\u003eKyle Sheahen is a\u0026nbsp;Partner in the Special Matters and Investigations practice in King \u0026amp; Spalding\u0026rsquo;s New York office. Kyle\u0026rsquo;s practice focuses on white collar criminal defense litigation, federal and state government investigations, corporate internal investigations, and advice concerning corporate compliance programs.\u003c/p\u003e\n\u003cp\u003eKyle has represented corporations and individuals in a wide array of matters, including FCPA/anti-corruption, Bank Secrecy Act/anti-money laundering, securities, false claims, taxation, and cybersecurity. He has advised clients in sectors such as banking, insurance brokerage, foreign exchange, energy, life sciences, and professional services. Kyle has handled investigations involving a range of federal, state, and foreign authorities, including the Justice Department, the Securities and Exchange Commission, the U.S. Senate, the New York State Department of Financial Services, and the Swiss Financial Market Supervisory Authority. Kyle has also worked on the ground in jurisdictions in Europe, the Middle East, South America,\u0026nbsp;and Asia to serve his clients\u0026rsquo; needs.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle is a commentator and speaker on various white collar and compliance topics, including data privacy and security, cross-border investigations and fraud in connection with the COVID-19 pandemic.\u003c/p\u003e\n\u003cp\u003eHe also serves on\u0026nbsp;\u003cem\u003eThe American Lawyer\u003c/em\u003e\u0026rsquo;s Young Lawyer Editorial Board and the board of directors of CUE Art Foundation in New York City.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eKyle earned his law degree from the University of California, Los Angeles, where he was a managing editor for the\u0026nbsp;\u003cem\u003eUCLA Journal of International Law and Foreign Affairs\u003c/em\u003e. Kyle also served as a law clerk for the U.S. Senate Committee on the Judiciary (Subcommittee on the Constitution) in Washington, D.C. He received his undergraduate degree in history from Cornell University.\u0026nbsp;\u003c/p\u003e","slug":"kyle-sheahen","email":"ksheahen@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting a global financial services company in connection with the launch of a mobile FinTech application for the international remittance of funds.\u003c/p\u003e","\u003cp\u003eDefending a businessman in an approximately $25 million fraud prosecution in the Western District of New York.\u003c/p\u003e","\u003cp\u003eDefending an international financial institution from enforcement actions based on conspiracy to commit tax fraud and securities violations brought by the Justice Department, the SEC, the Federal Reserve, and the New York State Department of Financial Services, and a related congressional inquiry by the Senate Permanent Subcommittee on Investigations; representing same company in connection with post-resolution undertakings, including the New York State Department of Financial Services-appointed monitorship.\u003c/p\u003e","\u003cp\u003eDefending a major financial institution in a criminal investigation by a U.S. Attorney\u0026rsquo;s Office and DOJ\u0026rsquo;s Asset Forfeiture \u0026amp; Money Laundering Section, regarding anti-money laundering and other issues related to allegations of fraud by a customer.\u003c/p\u003e","\u003cp\u003ePerforming internal compliance reviews and anticorruption analysis for a global insurance broker.\u003c/p\u003e","\u003cp\u003eRepresenting the CEO of a Fortune 500 company in connection with an insurance investigation by the New York County District Attorney\u0026rsquo;s Office.\u003c/p\u003e","\u003cp\u003eAdvising an international oil and gas company on FCPA compliance issues related to overseas projects.\u003c/p\u003e","\u003cp\u003ePreparing a financial firm\u0026rsquo;s response to subpoenas served by the Justice Department Tax Division.\u003c/p\u003e","\u003cp\u003eCounseling a Fortune 500 financial services company on its incident response plan following a data security breach.\u003c/p\u003e","\u003cp\u003eRepresenting a professional sports team owner in connection with an investigation by the Securities and Exchange Commission.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":1,"source":"capabilities"},{"id":38,"guid":"38.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":5,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":6,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":7,"source":"smartTags"},{"id":973,"guid":"973.smart_tags","index":8,"source":"smartTags"},{"id":113,"guid":"113.capabilities","index":9,"source":"capabilities"},{"id":1153,"guid":"1153.smart_tags","index":10,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":11,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":12,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":13,"source":"smartTags"},{"id":803,"guid":"803.smart_tags","index":14,"source":"smartTags"},{"id":132,"guid":"132.capabilities","index":15,"source":"capabilities"}],"is_active":true,"last_name":"Sheahen","nick_name":"Kyle","clerkships":[],"first_name":"Kyle","title_rank":9999,"updated_by":34,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/kyle-sheahen-7617b49/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Sheahen is a\u0026nbsp;Partner in the Special Matters and Investigations practice in King \u0026amp; Spalding\u0026rsquo;s New York office. Kyle\u0026rsquo;s practice focuses on white collar criminal defense litigation, federal and state government investigations, corporate internal investigations, and advice concerning corporate compliance programs.\u003c/p\u003e\n\u003cp\u003eKyle has represented corporations and individuals in a wide array of matters, including FCPA/anti-corruption, Bank Secrecy Act/anti-money laundering, securities, false claims, taxation, and cybersecurity. He has advised clients in sectors such as banking, insurance brokerage, foreign exchange, energy, life sciences, and professional services. Kyle has handled investigations involving a range of federal, state, and foreign authorities, including the Justice Department, the Securities and Exchange Commission, the U.S. Senate, the New York State Department of Financial Services, and the Swiss Financial Market Supervisory Authority. Kyle has also worked on the ground in jurisdictions in Europe, the Middle East, South America,\u0026nbsp;and Asia to serve his clients\u0026rsquo; needs.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle is a commentator and speaker on various white collar and compliance topics, including data privacy and security, cross-border investigations and fraud in connection with the COVID-19 pandemic.\u003c/p\u003e\n\u003cp\u003eHe also serves on\u0026nbsp;\u003cem\u003eThe American Lawyer\u003c/em\u003e\u0026rsquo;s Young Lawyer Editorial Board and the board of directors of CUE Art Foundation in New York City.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eKyle earned his law degree from the University of California, Los Angeles, where he was a managing editor for the\u0026nbsp;\u003cem\u003eUCLA Journal of International Law and Foreign Affairs\u003c/em\u003e. Kyle also served as a law clerk for the U.S. Senate Committee on the Judiciary (Subcommittee on the Constitution) in Washington, D.C. He received his undergraduate degree in history from Cornell University.\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eRepresenting a global financial services company in connection with the launch of a mobile FinTech application for the international remittance of funds.\u003c/p\u003e","\u003cp\u003eDefending a businessman in an approximately $25 million fraud prosecution in the Western District of New York.\u003c/p\u003e","\u003cp\u003eDefending an international financial institution from enforcement actions based on conspiracy to commit tax fraud and securities violations brought by the Justice Department, the SEC, the Federal Reserve, and the New York State Department of Financial Services, and a related congressional inquiry by the Senate Permanent Subcommittee on Investigations; representing same company in connection with post-resolution undertakings, including the New York State Department of Financial Services-appointed monitorship.\u003c/p\u003e","\u003cp\u003eDefending a major financial institution in a criminal investigation by a U.S. Attorney\u0026rsquo;s Office and DOJ\u0026rsquo;s Asset Forfeiture \u0026amp; Money Laundering Section, regarding anti-money laundering and other issues related to allegations of fraud by a customer.\u003c/p\u003e","\u003cp\u003ePerforming internal compliance reviews and anticorruption analysis for a global insurance broker.\u003c/p\u003e","\u003cp\u003eRepresenting the CEO of a Fortune 500 company in connection with an insurance investigation by the New York County District Attorney\u0026rsquo;s Office.\u003c/p\u003e","\u003cp\u003eAdvising an international oil and gas company on FCPA compliance issues related to overseas projects.\u003c/p\u003e","\u003cp\u003ePreparing a financial firm\u0026rsquo;s response to subpoenas served by the Justice Department Tax Division.\u003c/p\u003e","\u003cp\u003eCounseling a Fortune 500 financial services company on its incident response plan following a data security breach.\u003c/p\u003e","\u003cp\u003eRepresenting a professional sports team owner in connection with an investigation by the Securities and Exchange Commission.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":93}]},"capability_group_id":2},"created_at":"2026-01-07T04:51:15.000Z","updated_at":"2026-01-07T04:51:15.000Z","searchable_text":"Sheahen{{ FIELD }}Representing a global financial services company in connection with the launch of a mobile FinTech application for the international remittance of funds.{{ FIELD }}Defending a businessman in an approximately $25 million fraud prosecution in the Western District of New York.{{ FIELD }}Defending an international financial institution from enforcement actions based on conspiracy to commit tax fraud and securities violations brought by the Justice Department, the SEC, the Federal Reserve, and the New York State Department of Financial Services, and a related congressional inquiry by the Senate Permanent Subcommittee on Investigations; representing same company in connection with post-resolution undertakings, including the New York State Department of Financial Services-appointed monitorship.{{ FIELD }}Defending a major financial institution in a criminal investigation by a U.S. Attorney’s Office and DOJ’s Asset Forfeiture \u0026amp; Money Laundering Section, regarding anti-money laundering and other issues related to allegations of fraud by a customer.{{ FIELD }}Performing internal compliance reviews and anticorruption analysis for a global insurance broker.{{ FIELD }}Representing the CEO of a Fortune 500 company in connection with an insurance investigation by the New York County District Attorney’s Office.{{ FIELD }}Advising an international oil and gas company on FCPA compliance issues related to overseas projects.{{ FIELD }}Preparing a financial firm’s response to subpoenas served by the Justice Department Tax Division.{{ FIELD }}Counseling a Fortune 500 financial services company on its incident response plan following a data security breach.{{ FIELD }}Representing a professional sports team owner in connection with an investigation by the Securities and Exchange Commission.{{ FIELD }}Kyle Sheahen is a Partner in the Special Matters and Investigations practice in King \u0026amp; Spalding’s New York office. Kyle’s practice focuses on white collar criminal defense litigation, federal and state government investigations, corporate internal investigations, and advice concerning corporate compliance programs.\nKyle has represented corporations and individuals in a wide array of matters, including FCPA/anti-corruption, Bank Secrecy Act/anti-money laundering, securities, false claims, taxation, and cybersecurity. He has advised clients in sectors such as banking, insurance brokerage, foreign exchange, energy, life sciences, and professional services. Kyle has handled investigations involving a range of federal, state, and foreign authorities, including the Justice Department, the Securities and Exchange Commission, the U.S. Senate, the New York State Department of Financial Services, and the Swiss Financial Market Supervisory Authority. Kyle has also worked on the ground in jurisdictions in Europe, the Middle East, South America, and Asia to serve his clients’ needs.\nKyle is a commentator and speaker on various white collar and compliance topics, including data privacy and security, cross-border investigations and fraud in connection with the COVID-19 pandemic.\nHe also serves on The American Lawyer’s Young Lawyer Editorial Board and the board of directors of CUE Art Foundation in New York City. \nKyle earned his law degree from the University of California, Los Angeles, where he was a managing editor for the UCLA Journal of International Law and Foreign Affairs. Kyle also served as a law clerk for the U.S. Senate Committee on the Judiciary (Subcommittee on the Constitution) in Washington, D.C. He received his undergraduate degree in history from Cornell University.  Partner Cornell University Cornell Law School University of California-Los Angeles UCLA School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Western District of New York New York Representing a global financial services company in connection with the launch of a mobile FinTech application for the international remittance of funds. Defending a businessman in an approximately $25 million fraud prosecution in the Western District of New York. Defending an international financial institution from enforcement actions based on conspiracy to commit tax fraud and securities violations brought by the Justice Department, the SEC, the Federal Reserve, and the New York State Department of Financial Services, and a related congressional inquiry by the Senate Permanent Subcommittee on Investigations; representing same company in connection with post-resolution undertakings, including the New York State Department of Financial Services-appointed monitorship. Defending a major financial institution in a criminal investigation by a U.S. Attorney’s Office and DOJ’s Asset Forfeiture \u0026amp; Money Laundering Section, regarding anti-money laundering and other issues related to allegations of fraud by a customer. Performing internal compliance reviews and anticorruption analysis for a global insurance broker. Representing the CEO of a Fortune 500 company in connection with an insurance investigation by the New York County District Attorney’s Office. Advising an international oil and gas company on FCPA compliance issues related to overseas projects. Preparing a financial firm’s response to subpoenas served by the Justice Department Tax Division. Counseling a Fortune 500 financial services company on its incident response plan following a data security breach. Representing a professional sports team owner in connection with an investigation by the Securities and Exchange Commission.","searchable_name":"Kyle Sheahen","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":442766,"version":1,"owner_type":"Person","owner_id":5387,"payload":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","slug":"adam-solander","email":"asolander@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":28,"guid":"28.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":5,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Solander","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":101,"law_schools":[{"id":1562,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2007-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}],"linked_in_url":"https://www.linkedin.com/in/adamsolander/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6393}]},"capability_group_id":2},"created_at":"2025-11-13T04:56:44.000Z","updated_at":"2025-11-13T04:56:44.000Z","searchable_text":"Solander{{ FIELD }}{:title=\u0026gt;\"Named to Washington DC Rising Stars list\", :detail=\u0026gt;\"Super Lawyers, 2016-2018\"}{{ FIELD }}{:title=\u0026gt;\"Received Readers’ Choice Award\", :detail=\u0026gt;\"JD Supra, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Received Burton Award for Legal Writing\", :detail=\u0026gt;\"Burton Awards Program in association with the Library of Congress, 2014\"}{{ FIELD }}As a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.\nAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\nPrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security.  He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments. \nPreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch. Partner Named to Washington DC Rising Stars list Super Lawyers, 2016-2018 Received Readers’ Choice Award JD Supra, 2016 Received Burton Award for Legal Writing Burton Awards Program in association with the Library of Congress, 2014 West Virginia University West Virginia University College of Law Pennsylvania State University Pennsylvania State University, Dickinson School of Law West Virginia University West Virginia University College of Law District of Columbia District of Columbia Bar Association Member, American Health Lawyers Association","searchable_name":"Adam C. Solander","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null}]}}